COVID-19 mRNA Vaccine Development Services

In 2020, the global outbreak of CovID-19 caused a large amount of investment and research activities to develop vaccines. Many organizations are using published genomes to develop possible anti-SARS-CoV-2 vaccines. An mRNA vaccine against SARS-CoV-2, the causative virus, may show its advantages in a shorter time and become a valuable tool for disease prevention.

What do we provide?

Relying on advanced mRNA technology and rich experience in the development of mRNA vaccines, BOC RNA can design and synthesize mRNA sequences from DNA templates and produce laboratory-scale or GMP-level mRNA vaccines to match your application from research to clinical trials.

Why develop COVID-19 mRNA Vaccine?

• When the mRNA vaccine enters the cell, it can produce a protein similar to the viral antigen, thereby activating the immune response and producing antibodies that can specifically bind the protein and the real viral antigen.
• Compared with the traditional vaccine research and development process, the mRNA program reduces the recombinant protein production process and enables faster discovery and development into the clinic.
• Through computer program design, antigens can be quickly generated and tested in clinical models, thereby speeding up vaccine screening.

Since the emergence of the new coronavirus (COVID-19), BOC RNA has stepped up our efforts and is committed to research and development of vaccines and treatments to contain the virus. We will continue to maintain industry cooperation to achieve the greatest chance of success.

More Information

Other COVID-19 Related Services
Liposomes Drug Delivery Services For COVID-19
Custom Oligo Synthesis Services For COVID-19 Research

COVID-19 Resources & News